Efficacité et tolérance à long terme du lénalidomide dans le traitement du lupus érythémateux cutané : étude rétrospective multicentrique de 40 patients von Aitmehdi, R., Arnaud, L., Frances, C., Senet, P., Monfort, J.-B., De Risi-Pugliese, T., Barbaud, A., Cohen-Aubart, F., Mathian, A., Le Guern, V., Costedoat-Chalumeau, N., Mékinian, A., Fain, O., Haroche, J., Pha, M., Amoura, Z., Chasset, F.

Volltext

Arrêt des anti-PD1 dans le mélanome métastatique en réponse complète von Aitmehdi, R., Fort, M., Longvert, C., Finet, A., Blom, A., Gonzales-Lara, L., Kassem, O., Lemercier, F., Emile, J.-F., Boru, B., Saiag, P.

Volltext

The determination of dielectric loss tangent by microwave phase tomography von Aitmehdi, R, Anderson, A P, Sali, S, Ferando, M

Volltext

30 Refractory cutaneous lupus: use of thalidomide or lenalidomide for refractory lupus skin disease von Chasset, Francois

Volltext

Response to rituximab of pseudotumoral digital nodules in a patient with granulomatosis with polyangiitis with alpha‐1 antitrypsin deficiency: A case report von Aitmehdi, Raphaël, Moguelet, Philippe, Godot, Sophie, Chazerain, Pascal, Senet, Patricia, Barbaud, Annick, Frances, Camille, Chasset, François

Volltext

Aiolos represses CD4+ T cell cytotoxic programming via reciprocal regulation of TFH transcription factors and IL-2 sensitivity von Read, Kaitlin A., Jones, Devin M., Pokhrel, Srijana, Hales, Emily D. S., Varkey, Aditi, Tuazon, Jasmine A., Eisele, Caprice D., Abdouni, Omar, Saadey, Abbey, Leonard, Melissa R., Warren, Robert T., Powell, Michael D., Boss, Jeremy M., Hemann, Emily A., Yount, Jacob S., Xin, Gang, Ghoneim, Hazem E., Lio, Chan-Wang J., Freud, Aharon G., Collins, Patrick L., Oestreich, Kenneth J.

Volltext

Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos von Jones, Devin M, Tuazon, Jasmine A, Read, Kaitlin A, Leonard, Melissa R, Pokhrel, Srijana, Sreekumar, Bharath K, Warren, Robert T, Yount, Jacob S, Collins, Patrick L, Oestreich, Kenneth J

Volltext

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update von Fanouriakis, Antonis, Kostopoulou, Myrto, Andersen, Jeanette, Aringer, Martin, Arnaud, Laurent, Bae, Sang-Cheol, Boletis, John, Bruce, Ian N., Cervera, Ricard, Doria, Andrea, Dörner, Thomas, Furie, Richard A., Gladman, Dafna D., Houssiau, Frederic A., Inês, Luís Sousa, Jayne, David, Kouloumas, Marios, Kovács, László, Mok, Chi Chiu, Morand, Eric F., Moroni, Gabriella, Mosca, Marta, Mucke, Johanna, Mukhtyar, Chetan B., Nagy, György, Navarra, Sandra, Parodis, Ioannis, Pego-Reigosa, José M., Petri, Michelle, Pons-Estel, Bernardo A., Schneider, Matthias, Smolen, Josef S., Svenungsson, Elisabet, Tanaka, Yoshiya, Tektonidou, Maria G., Teng, Yk Onno, Tincani, Angela, Vital, Edward M., van Vollenhoven, Ronald F., Wincup, Chris, Bertsias, George, Boumpas, Dimitrios T.

Volltext

Toward a pathophysiology inspired treatment of VEXAS syndrome von Heiblig, Maël, Patel, Bhavisha A., Groarke, Emma M., Bourbon, Estelle, Sujobert, Pierre

Volltext

31 Osteonecrosis: prevention and treatment von Pons-Estel, Bernardo

Volltext

29 Treatment of CAPS: which drugs and in which order? von Chambrun, Marc Pineton de

Volltext

Lenalidomide for systemic lupus erythematosus with refractory cutaneous eruptions von Wang, Xiaoqi, Li, Mengtao, Zeng, Xiaofeng, Wang, Qian

Volltext

Civil Marine Radar – A Fresh Look at Transmitter Spectral Control and Diversity Operation von Williams, P. D. L.

Volltext

Clinical Images: Chronic, refractory childhood‐onset cutaneous lupus erythematosus of the face responsive to lenalidomide von Sherman, Matthew A., Srinivasalu, Hemalatha, Kirkorian, A. Yasmine, Cardis, Michael A.

Volltext

Prevalence and factors associated with long-term remission in cutaneous lupus: A longitudinal cohort study of 141 cases von Fayard, Damien, Francès, Camille, Amoura, Zahir, Breillat, Paul, Mathian, Alexis, Senet, Patricia, Barbaud, Annick, Arnaud, Laurent, Chasset, François

Volltext

A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus von Curtiss, Paul, Walker, Amanda M, Chong, Benjamin F

Volltext

Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions von Niebel, Dennis, de Vos, Luka, Fetter, Tanja, Brägelmann, Christine, Wenzel, Jörg

Volltext

Advances in the pharmacological management of systemic lupus erythematosus von Tsoi, Alexander, Nikolopoulos, Dionysis, Parodis, Ioannis

Volltext

Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy von Chatziioannou, Eftychia, Leiter, Ulrike, Thomas, Ioannis, Keim, Ulrike, Seeber, Olivia, Meiwes, Andreas, Boessenecker, Isabell, Gonzalez, Stephanie Sanchez, Torres, Francisco Merraz, Niessner, Heike, Sinnberg, Tobias, Forschner, Andrea, Flatz, Lukas, Amaral, Teresa

Volltext

Recent Insight on the Management of Lupus Erythematosus Alopecia von Desai, Karishma, Miteva, Mariya

Volltext